About Cephalon
Cephalon is a Healthcare company based in Frazer (United States) founded in 1987, and was acquired by Teva Pharmaceuticals in October 2011. Therapeutics for central nervous system disorders, pain, and cancer. Cephalon has completed 6 acquisitions, including Arana, Ception Therapeutics and ChemGenex Pharmaceuticals. Its focus areas include Diversified Pharmaceuticals.
Company details
Founded in 1987 and headquartered in Frazer, United States, Cephalon is involved in the pharmaceutical sector, where therapeutics for central nervous system disorders, pain management, and oncology are developed, manufactured, and marketed. Products such as Nuvigil for narcolepsy, Treanda for non-Hodgkins lymphoma and chronic lymphocytic leukemia, and Amrix as a muscle relaxant are offered. Operations as a subsidiary of Teva Pharmaceuticals have been maintained since October 2011.
- Headquarters Frazer, United States
- Stage Acquired
- SectorsHealthcare
- Website cephalon.com
- Social LinkedIn
- Acquired by Teva Pharmaceuticals (Oct 2011)
- Investors
- Investments & AcquisitionsArana
& 5 more
- Acquired byTeva Pharmaceuticals
(Oct 2011)
Investors in Cephalon
Cephalon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Teva Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | tevapharm.com | Petah Tikva, Israel |
Investor details for Cephalon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cephalon
Cephalon has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Arana, Ception Therapeutics and ChemGenex Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Specialty company developing oncology drugs | chemgenex.com | Geelong, Australia | 1999 | Mar 2011 | $159M | |
Cancer therapeutics and drugs are discovered, developed, and manufactured. | geminx.com | Malvern, United States | 1998 | Mar 2011 | $225M | |
Drugs for inflammatory conditions are discovered, developed, and commercialized. | ceptiontx.com | Malvern, United States | 2004 | Feb 2010 | $250M | |
Limited information available | arana.com | 1995 | Feb 2009 | $328M | ||
PDF document processing solutions for creation and management are provided. | trisenox.com | 0 | Jun 2005 | $100M | ||
Drugs for hematologic cancers are developed using prior clinical data. | salmedix.com | San Diego, United States | 2000 | May 2005 | •••• |
Complete acquisition details for Cephalon
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cephalon
8 dated milestones of Cephalon across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Cephalon is founded.
- Acquisition Acquires Salmedix.
- Acquisition Acquires Trisenox.
- Acquisition Acquires Arana.
- Acquisition Acquires Ception Therapeutics.
- Acquisition Acquires Gemin X Pharmaceuticals.
- Acquisition Acquires ChemGenex Pharmaceuticals.
- Exit Acquired by Teva Pharmaceuticals.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Cephalon (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cephalon
Complete news archive for Cephalon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cephalon
Cephalon was founded in 1987.
Cephalon is headquartered in Frazer, United States. It is registered at Frazer, Pennsylvania, United States.
Founded in 1987 and headquartered in Frazer, United States, Cephalon is involved in the pharmaceutical sector, where therapeutics for central nervous system disorders, pain management, and oncology are developed, manufactured, and marketed. Products such as Nuvigil for narcolepsy, Treanda for non-Hodgkins lymphoma and chronic lymphocytic leukemia, and Amrix as a muscle relaxant are offered. Operations as a subsidiary of Teva Pharmaceuticals have been maintained since October 2011.
Cephalon has made 6 acquisitions, including Arana, Ception Therapeutics, and ChemGenex Pharmaceuticals.
Cephalon has 1 investor. Key investors include Teva Pharmaceuticals.
Yes. Cephalon was acquired by Teva Pharmaceuticals in October 2011.